Similar Search Results

What's in the box? : combating counterfeit medications in pharmaceutical supply chains with blockchain vigilant information systems

Clohessy, Trevor; Clohessy, Saima - In: Blockchain and distributed ledger technology use cases …, (pp. 51-68). 2020

Persistent link: https://www.econbiz.de/10012232736

Genuine medicine? : why safeguarding the pharmaceutical supply chain from counterfeit drugs with RFID is vital for protecting public health and the health of the pharmaceutical ind...

Wyld, David C. - In: Competitiveness review : an international business … 18 (2008) 3, pp. 206-216

Persistent link: https://www.econbiz.de/10003929339

Blockchain concept to combat drug counterfeiting by increasing supply chain visibility

Trautmann, Lorenz; Hübner, Tim; Lasch, Rainer - In: International journal of logistics : research and … 27 (2024) 6, pp. 959-985

Persistent link: https://www.econbiz.de/10014554076

Blockchain for Combating Pharmaceutical Drug Counterfeiting and Cold Chain Distribution

Sarkar, Shambhu - 2023

digital supply chain's transparency and visibility. Blockchain-based drug traceability proposes a promising solution to create … provides a thorough analysis and summary of the current state of drug traceability distribution research on the blockchain … platform by using Hyperledger febric and Hyperledger Besu methodologies. Blockchain based platform, Hyperledger Fabric and Besu …

Persistent link: https://www.econbiz.de/10014345734

Assessment of blockchain technology as remedy to counterfeit drugs problem in pharmaceutical supply chain and implementation approach

Thakuriya, Pulkit; Kaur, Sumeet; Mishra, Vinaytosh - In: Operations research forum 4 (2023) 2, pp. 1-16

Persistent link: https://www.econbiz.de/10014330482

Decision criteria for partial nationalization of pharmaceutical supply chain : a scoping review

Marrone, Patrícia Véras; Mathias, Fabio Rampazzo; … - In: Economies : open access journal 11 (2023) 1, pp. 1-21

(1) Background: Any disturbance in the pharmaceutical supply chain (PSC) can disrupt the supply of medicines and affect the efficiency of health systems. Due to shortages in the global pharma supply chain over the past few years and the complex nature of free trade and its limitations when...

Persistent link: https://www.econbiz.de/10013500649